Cell

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S. Schiergens, Georg Herrler, Nai‐Huei Wu, Andreas Nitsche, Marcel A. Müller, Christian Drosten and 1 more

Journal article · 2020 · Cited by 20,440